Concepedia

Publication | Closed Access

Phase II evaluation of interferon α-2a for progressive or recurrent craniopharyngiomas

DOI

82

Citations

25

References

2000

Year

Regina I. Jakacki, Bruce H. Cohen, Cheryl Sorenson Jamison, Vincent P. Mathews, Edward B. Arenson, Darryl C. Longee, Joanne M. Hilden, Al Cornelius, Michael N. Needle, Doug Heilman,
Journal of neurosurgery

Abstract

Interferon-alpha-2a is active against some childhood craniopharyngiomas; its toxicity precludes administration of high daily doses, and the optimum dose level and schedule remain to be defined.

References

YearCitations

Page 1